Login / Signup

An overview of the efficacy and safety of β 2 -Adrenoceptor antagonists for the treatment of chronic obstructive pulmonary disease.

Maria Gabriella MateraPaola RoglianiLuigino CalzettaMario Cazzola
Published in: Expert opinion on drug safety (2024)
-AR antagonists in COPD, balancing cardiovascular benefits with potential respiratory risks to enhance outcomes and quality of life for individuals living with this debilitating respiratory condition.
Keyphrases
  • human health
  • chronic obstructive pulmonary disease
  • respiratory tract
  • adipose tissue
  • skeletal muscle
  • air pollution